susan golder : Citation Profile

Are you susan golder?

University of York

2

H index

0

i10 index

21

Citations

RESEARCH PRODUCTION:

10

Articles

1

Papers

RESEARCH ACTIVITY:

   11 years (2011 - 2022). See details.
   Cites by year: 1
   Journals where susan golder has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 3 (12.5 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pgo960
   Updated: 2024-04-18    RAS profile: 2022-09-29    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with susan golder.

Is cited by:

Cites to:

Sculpher, Mark (1)

EPSTEIN, DAVID (1)

Main data

Where susan golder has published?

Journals with more than one article published# docs
Drug Safety6
PLOS Medicine2

Recent works citing susan golder (2024 and 2023)

YearTitle of citing document

Works by susan golder:

YearTitleTypeCited
2021Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews In: Social Science & Medicine.
[Full Text][Citation analysis]		article0
2021Who is Tweeting? A Scoping Review of Methods to Establish Race and Ethnicity from Twitter Datasets In: SocArXiv.
[Full Text][Citation analysis]		paper0
2011Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview In: PLOS Medicine.
[Full Text][Citation analysis]		article9
2016Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review In: PLOS Medicine.
[Full Text][Citation analysis]		article6
2013Comparison of Pooled Risk Estimates for Adverse Effects from Different Observational Study Designs: Methodological Overview In: PLOS ONE.
[Full Text][Citation analysis]		article2
2018Inadequate harms reporting in randomized control trials of antibiotics for pediatric acute otitis media: a systematic review In: Drug Safety.
[Full Text][Citation analysis]		article0
2018Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab In: Drug Safety.
[Full Text][Citation analysis]		article2
2019Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy In: Drug Safety.
[Full Text][Citation analysis]		article1
2021A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews In: Drug Safety.
[Full Text][Citation analysis]		article0
2021Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews In: Drug Safety.
[Full Text][Citation analysis]		article0
2022Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media In: Drug Safety.
[Full Text][Citation analysis]		article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 4 2024. Contact: CitEc Team